Scott Gottlieb Proposes AI Rules for Medical Centers
A new framework aims to bring academic hospital artificial intelligence under federal oversight.
Updated on Oct. 15, 2026 in Artificial Intelligence
Live Poll
Should Congress enact stricter federal regulatory oversight for AI models used in academic medical centers?
Scott Gottlieb has proposed a federal regulatory framework to oversee artificial intelligence models developed within academic medical centers. The plan seeks to eliminate the two-tier market currently separating these internal systems from commercial device developers.
Why it matters
Inconsistent testing and vetting protocols at medical institutions have created a need for standardized oversight. Current internal AI usage often bypasses FDA review, potentially resulting in unequal standards of care compared to commercial tools.
Currently, 61% of hospitals utilizing predictive models perform local accuracy testing, while 44% conduct bias assessments on their algorithms. These practices often operate internally to avoid federal FDA oversight requirements.
The players
Scott Gottlieb
He is a fellow at the American Enterprise Institute who has previously served as the Commissioner of the Food and Drug Administration.
Brian Richard Jackson
He is an author who published research regarding the evolving regulatory environment for artificial intelligence in 2025.
The details
The proposed plan would require the FDA to certify health systems for the development and deployment of specific AI categories while mandating regular performance reporting. Implementing this structure would require new federal legislation from Congress to replace current pathways like the Clinical Laboratory Improvement Amendments.
Timeline
A 2025 study by Brian Richard Jackson addressed aspects of AI regulation.
Scott Gottlieb published his specific proposal on October 15, 2026.
The Tech Race
The proposal seeks to modernize health oversight by shifting AI development away from the standards set by the Clinical Laboratory Improvement Amendments. This aligns academic medical center innovation with the more rigorous, centralized regulatory trajectory established for commercial medical devices.
Patients may see more consistent safety and accuracy standards in diagnostic tools as hospitals adopt standardized federal reporting requirements. These changes could reduce internal development biases while potentially increasing the time required for medical centers to roll out new features.
The takeaway
Standardizing AI regulation is a critical step as hospitals continue to integrate predictive models into their diagnostic workflows. Implementing these federal rules could bridge the gap between academic innovation and the safety protocols required for widespread medical adoption.
Further reading
Learn more about evolving digital health standards in the Artificial Intelligence section.
Source note: This article includes information reported by Raps.
Live Poll
Should Congress enact stricter federal regulatory oversight for AI models used in academic medical centers?
